ALBIO.PA
Price:
$4.45
Market Cap:
$47.89M
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests in France and internationally. The company offers a range of rapid diagnostic tests, immunoblots, molecular biology, and point of care products for screening, diagnosis, and prevention in the areas of bacteriology, parasitology, mycology, virology, biochemistry and oncology, and women's health, as well as COVID-19 tests and instruments. It also provides self-tests; self-measurement products, including thermometers and blood pressure monitors; and oral care and medical aid products. The company provides its products to biology and medical analysis laboratories, hospitals, pharmacies, hyper and supermarkets, etc. It also...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2011-03-28
Stock Exchange
EURONEXT
Ticker
ALBIO.PA
According to Biosynex SA’s latest financial reports and current stock price. The company's current PE Ratio is -1.29. This represents a change of 55.30% compared to the average of -0.83 of the last 4 quarters.
The mean historical PE Ratio of Biosynex SA over the last ten years is -2.96. The current -1.29 PE Ratio has changed 4.25% with respect to the historical average. Over the past ten years (40 quarters), ALBIO.PA's PE Ratio was at its highest in in the June 2016 quarter at 475.60. The PE Ratio was at its lowest in in the January 2010 quarter at -784.87.
Average
-2.96
Median
3.73
Minimum
-148.17
Maximum
94.48
Discovering the peaks and valleys of Biosynex SA PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.39%
Maximum Annual PE Ratio = 94.48
Minimum Annual Increase = -163.76%
Minimum Annual PE Ratio = -148.17
Year | PE Ratio | Change |
---|---|---|
2023 | -2.42 | -126.78% |
2022 | 9.04 | 246.08% |
2021 | 2.61 | -46.10% |
2020 | 4.84 | -77.61% |
2019 | 21.63 | -48.58% |
2018 | 42.07 | -55.47% |
2017 | 94.48 | -163.76% |
2016 | -148.17 | 194.45% |
2015 | -50.32 | 1.39% |
2014 | -3.39 | -11.51% |
The current PE Ratio of Biosynex SA (ALBIO.PA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
3.08
5-year avg
7.14
10-year avg
-2.96
Biosynex SA’s PE Ratio is greater than Novacyt S.A. (-1.81), less than Eurobio Scientific Société anonyme (47.01), less than Biophytis S.A. (-0.05), greater than Intrasense SA (-4.28), less than Theradiag SA (25.79),
Company | PE Ratio | Market cap |
---|---|---|
-1.81 | $69.50M | |
47.01 | $241.29M | |
-0.05 | $2.60M | |
-4.28 | $15.34M | |
25.79 | $17.29M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Biosynex SA using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Biosynex SA or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Biosynex SA's PE Ratio?
How is the PE Ratio calculated for Biosynex SA (ALBIO.PA)?
What is the highest PE Ratio for Biosynex SA (ALBIO.PA)?
What is the 3-year average PE Ratio for Biosynex SA (ALBIO.PA)?
What is the 5-year average PE Ratio for Biosynex SA (ALBIO.PA)?
How does the current PE Ratio for Biosynex SA (ALBIO.PA) compare to its historical average?